Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bruker Corporation to Present at the 15th Annual Morgan Stanley Global Healthcare Conference

BRKR

PR Newswire

BILLERICA, Mass., Sept. 5, 2017 /PRNewswire/ -- Bruker Corporation (NASDAQ: BRKR) announced today it will present at the 15th Annual Morgan Stanley Global Healthcare Conference. Juergen Srega, President of the Bruker CALID Group, will participate in a "fireside chat" Q&A session on behalf of the company on Monday, September 11th, 2017 at 1:40 PM Eastern Time.  

A live audio webcast of the presentation will be available on the Investor section of the Company's website at http://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation website after the event and will be available for 30 days following the presentation.

About Bruker Corporation

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life.  Bruker's high-performance scientific instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.  In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nanoanalysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics.  For more information, please visit: www.bruker.com.  

Contact
Miroslava Minkova
Head of Investor Relations 
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479  
miroslava.minkova@bruker.com                                                            

View original content:http://www.prnewswire.com/news-releases/bruker-corporation-to-present-at-the-15th-annual-morgan-stanley-global-healthcare-conference-300514057.html

SOURCE Bruker Corporation